WHC is still in active development. Read this to understand our approach.
depiction of WVLOADHCBXTIJK-UHFFFAOYSA-N.svg
tripsit

hydromorphone

Verificar en tripsit

psychonaut

Hydromorphone

Verificar en psychonaut

isomerdesign

Hydromorphone

Verificar en isomerdesign

pubchem

Hydromorphone

Verificar en pubchem

druglab

Hydromorphone

Verificar en druglab

drugmap

Hydromorphone

Verificar en drugmap

wiki

Hydromorphone

Verificar en wiki

Data

InChI: InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2,4,10-11,16,19H,3,5-8H2,1H3

Sinónimos: SCHEMBL2255,Idromorfone [DCIT], (5alpha)-3-hydroxy-17-methyl-4,5-epoxymorphinan-6-one,4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one,Hydromorphone 1.0 mg/ml in Methanol, Hydromorfona,Dilaudid,Hydromorfona,Hydromorphone solution, 1 mg/mL in methanol, ampule of 1 mL, certified reference material,Dihydromorfinon [Czech], 7,8-Dihydromorphinone, (-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one, Dilaudid-hp,(-)-Hydromorphone,(1S,5R,13R,17R)-10-hydroxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-one,hydromorphone,6-Deoxy-7,8-dihydro-6-oxomorphine, Morphinone, dihydro-,Hydromorphone,HYDROCODONE HYDROGEN TARTRATE 2.5-HYDRATE IMPURITY K [EP IMPURITY], 4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one,BDBM50241341, Dihydromorphinone, Idromorfone [DCIT],DEA No. 9150,HYDROMORPHONE [INN],HSDB 3341,Dimorphone,Hydromorphone [INN:BAN], 4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone,ZINC402954, Hydromorphone (INN),Laudacon,3-hydroxy-17-methyl-4,5alpha-epoxymorphinan-6-one, Hydromorphone HCL, Hidromorfona [INN-Spanish],Hydromorphone Form II,(4R,4aR,7aR,12bS)-9-hydroxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one,(5alpha)-3-hydroxy-17-methyl-4,5-epoxymorphinan-6-one,Morphinan-6-one, 4,5-epoxy-3-hydroxy-17-methyl-, (5alpha)-,CHEMBL398707,Hydromorphone form I,IDS-NH-004,(4R,4aR,7aR,12bS)-9-hydroxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one,EINECS 207-383-5,WLN: T B6566 B6/CO 4ABBC R BX FV HO PN GHT&&TTJ JQ P1, Idromorfone,DB00327,Laudicon, Hydromorphon,Morphinan-6-one,5.alpha.-epoxy-3-hydroxy-17-methyl-, Morphinan-6-one, 4,5alpha-epoxy-3-hydroxy-17-methyl-(8CI),Idromorfone, Palladone SR (TN),HYDROMORPHONE [VANDF],C07042,Q812464R06,Hydromorphone 0.1 mg/ml in Methanol, Hidromorfona,4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone,Dihydromorphinone,(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one, Hydromorphonum, Dimorphone,GTPL7082, Dilaudid Oros, Hydromorphonum [INN-Latin],Hidromorfona, Palladone, (-)-Hydromorphone,HYDROMORPHONE [WHO-DD],Morphinan-6-one, 4,5-epoxy-3-hydroxy-17-methyl-, (5.alpha.)-, Laudacon,HYDROMORPHONE [MI],Dilaudid Oros, Dilaudid,4,5.alpha.-Epoxy-3-hydroxy-17-methylmorphinan-6-one, 466-99-9, Hydromorphone prodrug,Morphinone, dihydro-,NSC-19046,DTXSID8023133, DiMo,DiMo,UNII-Q812464R06,D08047,Palladone,NSC 19046, Dihydromorfinon, Laudicon, Hydromorfona [Spanish], 3-hydroxy-17-methyl-4,5alpha-epoxymorphinan-6-one, Hydromorphone [INN:BAN],(1S,5R,13R,17R)-10-hydroxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0?,??.0?,??.0?,??]octadeca-7,9,11(18)-trien-14-one,Jurnista, Novolaudon,NSC19046,Dihydromorfinon,Hidromorfona [INN-Spanish], Dilaudid (TN),Morphinan-6-one, 4,5-alpha-epoxy-3-hydroxy-17-methyl-,Hydromorfona [Spanish],dilaudid,Novolaudon,Morphinan-6-one, 4,5alpha-epoxy-3-hydroxy-17-methyl-,N02AA03,Hydromorphonum, Dihydromorfinon [Czech], Palladone (TN),Hydromorphone (INN), 6-Deoxy-7,8-dihydro-6-oxomorphine,Q303646,Hydromorphonum [INN-Latin],(4R,4aR,7aR,12bS)-9-Hydroxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one],CHEBI:5790,Morphinan-6-one,5-epoxy-3-hydroxy-17-methyl-, (5.alpha.)-,Hydromorphon,466-99-9, DiMo,7,8-Dihydromorphinone,HYDROMORPHONE [HSDB],diluadid,Dilaudid-hp

Estimated data

Solubilidad: -2.934 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 100.0% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.